ECS01 MULTIFOCAL IOLS SEE-THROUGH SIMULATOR – ENHANCING THE PATIENT EXPERIENCE WITH A TAILORED IOL SELECTION S. Marcos1,2,* 12EyesVision, Madrid, Spain, 2University of Rochester, Rochester, United States Presbyopia affects 100% of the population above 45 years old and cataracts 45% of the population above 75. The surgical correction for these conditions – affecting 1.8 billion people […]
EYE-PCR B.V. is a science and technology based emerging company, applying innovation to improve cataract surgery outcomes. fixOflex, an artificial capsule reconstructor ring, surgically implanted in the lens capsule after phacoemucification and prior to IOL implantation by using a standard injector. After placement of the fixOflex in the capsule, the IOL is injected, placed, and […]
Based in Seattle, Boston and Tokyo, Aurion Biotech is a clinical-stage biotech company. Our mission is to restore vision to millions of patients with our life-changing regenerative therapies. Our first product candidate is for the treatment of corneal edema secondary to endothelial dysfunction, and is one of the first clinically validated cell therapies for corneal […]
Established in 2016, NovaSight is a growing medical device company with a mission to prevent vision impairments among pediatric patients using eye tracking based technology in novel diagnostic, therapeutic and preventive solutions, especially designed for the unique needs of children. NovaSight offers two flagship products both ideally positioned for objective diagnostics and remote home treatment: […]
TearClear is a clinical stage ophthalmic pharmaceutical business that is transforming trusted drugs into best-in-class therapies. The company’s glaucoma portfolio offers patients preservative-free doses delivered directly from preserved solutions. The lead candidate is nearing Pivotal Study completion for approval in the US with three candidates swiftly following. Current preserved medications for chronic eye diseases are […]
Custom Surgical GmbH was funded in August of 2019 in Munich, Germany. We focus our work on the development of smartphone applications and optical systems for ophthalmology. During the past 2 and a half years we have reached more than 60 countries with our flagship product, the MicroREC. The MicroREC is an optical system that […]
Eyemetagenomics LTD is a UK-based company with the aim to develop diagnostic tolls in eye-microbiome. The first developed product is LUCY. LUCY is the solution to integrate microbiome analysis into your clinical practice. LUCY is designed to help healthcare professionals offer personalized medical advices to patients. The microbiome of each human body organ is unique, and […]
At Samsara Vision, we recognize that central vision loss from late-stage age-related macular degeneration (AMD) can make it difficult for individuals to connect with the world around them. Our proprietary telescopic implant technology, SING IMT™, is intended to significantly improve central vision for late-stage AMD patients and help them regain their visual independence. SING IMT […]
easee, has developed proprietary web-based technology allowing for remote vison and refraction assessment. With just a laptop and a smartphone, patients can assess and monitor their vision from the comfort of their home. We have studied the applicability and robustness of this technology in a number of clinical use cases: cataract post operative follow […]
About iSTAR Medical iSTAR Medical is committed to delivering breakthrough eye care solutions. Our most advanced product, MINIject®, is approved in Europe for the treatment of open-angle glaucoma – the leading cause of irreversible blindness – and we are aiming to seek market approval in the US. We believe MINIject®’s distinctive tissue-integrating capabilities unlock a […]
